Novel Tanshinone II A ternary solid dispersion pellets prepared by a single-step technique: In vitro and in vivo evaluation

被引:47
作者
Li, Jin [1 ]
Liu, Pan [1 ]
Liu, Jian-Ping [1 ]
Zhang, Wen-Li [1 ]
Yang, Ji-Kun [1 ]
Fan, Yong-Qing [1 ]
机构
[1] China Pharmaceut Univ, Dept Pharmaceut, Nanjing 210009, Peoples R China
关键词
Ternary solid dispersion pellets; Combined carriers; Polyvinylpyrrolidone; Poloxamer; 188; In vitro dissolution study; In vivo evaluation; WATER-SOLUBLE DRUGS; POLYETHYLENE GLYCOL-GRISEOFULVIN; RELEASE DOSAGE FORMS; DISSOLUTION PROPERTIES; ORAL BIOAVAILABILITY; SYSTEM; PHARMACOKINETICS; SURFACTANTS; SOLUBILITY; STABILITY;
D O I
10.1016/j.ejpb.2011.11.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Novel Tanshinone II A (TA) ternary solid dispersion (tSD) pellets with the combination of polyvinylpyrrolidone and poloxamer 188 as dispersing carriers were prepared by a single-step technique. A formulation screening study showed that the addition of poloxamer 188 to binary TA-PVP system could remarkably promote the dissolution rate of TA from 60% to 100% after 60 min. Scanning electron microscopy study revealed a smooth surface and a tightly packed coating structure. Differential scanning calorimetry analysis confirmed the formation of solid dispersions. In vivo test showed that TA tSD pellets presented significantly larger AUC(O-t), which was 0.76 times more than that of binary solid dispersion (bSD) pellets, 2.87 times more than that of physical mixtures (PMs) and 5.40 times more than that of TA. C-max of TA tSD pellets also increased by 1.82-8.97-fold as that of bSD pellets. PMs and TA. TA tSD pellets generated obviously shortened T-max of (3.80 +/- 0.398) h, compared to bSD pellets with (4.15 +/- 0.456) h, PMs with (4.65 +/- 0.226) h and TA with (5.52 +/- 0.738) h. In conclusion, the addition of poloxamer 188 to pellets containing PVP-based solid dispersions could achieve complete dissolution, accelerated absorption rate and superior oral bioavailability. The fluid-bed technique becomes an alternative approach to obtain solid dispersion-coated pellets. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:426 / 432
页数:7
相关论文
共 52 条
  • [1] THE PREPARATION AND STABILITY OF FAST RELEASE FUROSEMIDE-PVP SOLID DISPERSION
    AKBUGA, J
    GURSOY, A
    KENDI, E
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1988, 14 (10) : 1439 - 1464
  • [2] STRUCTURE OF SOLID DISPERSIONS IN THE SYSTEM POLYETHYLENE GLYCOL-GRISEOFULVIN WITH ADDITIONS OF SODIUM DODECYL-SULFATE
    ALDEN, M
    TEGENFELDT, J
    SJOKVIST, E
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 83 (1-3) : 47 - 52
  • [3] STRUCTURES FORMED BY INTERACTIONS IN SOLID DISPERSIONS OF THE SYSTEM POLYETHYLENE GLYCOL-GRISEOFULVIN WITH CHARGED AND NONCHARGED SURFACTANTS ADDED
    ALDEN, M
    TEGENFELDT, J
    SAERS, ES
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 94 (1-3) : 31 - 38
  • [4] THE APPLICATION OF SOLID DISPERSION TECHNIQUE WITH D-MANNITOL TO THE IMPROVEMENT IN ORAL ABSORPTION OF TRIAMTERENE
    ARIAS, MJ
    GINES, JM
    MOYANO, JR
    RABASCO, AM
    [J]. JOURNAL OF DRUG TARGETING, 1994, 2 (01) : 45 - 51
  • [5] Physicochemical studies on solid dispersions of poorly water-soluble drugs - Evaluation of capabilities and limitations of thermal analysis techniques
    Bikiaris, D
    Papageorgiou, GZ
    Stergiou, A
    Pavlidou, E
    Karavas, E
    Kanaze, F
    Georgarakis, M
    [J]. THERMOCHIMICA ACTA, 2005, 439 (1-2) : 58 - 67
  • [6] Characterization and stability of solid dispersions based on PEG/polymer blends
    Bley, Heike
    Fussnegger, Bernd
    Bodmeier, Roland
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 390 (02) : 165 - 173
  • [7] EFFECT OF DOCUSATE SODIUM ON DRUG RELEASE FROM A CONTROLLED-RELEASE DOSAGE FORM
    CHAMBLISS, WG
    CLEARY, RW
    FISCHER, R
    JONES, AB
    SKIERKOWSKI, P
    NICHOLES, W
    KIBBE, AH
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1981, 70 (11) : 1248 - 1251
  • [8] MECHANISMS OF DISSOLUTION OF FAST RELEASE SOLID DISPERSIONS
    CORRIGAN, OI
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1985, 11 (2-3) : 697 - 724
  • [9] Ford J.L., 1986, DRUG DEV IND PHARM, V12, P1777
  • [10] Extrusion and spheronization in the development of oral controlled-release dosage forms
    Gandhi, R
    Kaul, CL
    Panchagnula, R
    [J]. PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1999, 2 (04): : 160 - 170